See more : Umuthi Healthcare Solutions Plc (UHS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Hektas Ticaret T.A.S. (HEKTS.IS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hektas Ticaret T.A.S., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Datacolor AG (DCN.SW) Income Statement Analysis – Financial Results
- MGC Pharmaceuticals Limited (MXC.AX) Income Statement Analysis – Financial Results
- Webjet Limited (WEBJF) Income Statement Analysis – Financial Results
- iMD Companies, Inc. (ICBU) Income Statement Analysis – Financial Results
- Huhtamäki Oyj (0K9W.L) Income Statement Analysis – Financial Results
Hektas Ticaret T.A.S. (HEKTS.IS)
About Hektas Ticaret T.A.S.
Hektas Ticaret T.A.S. produces, imports, and markets agricultural and veterinary pesticides and fertilizers in Turkey. Its crop protection products include fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nematicides and soil fumigants, plant growth regulators, winter struggle medicines and summer oils, and spread adhesives. The company also offers leaf fertilizers, organ minerals, drip irrigation, and other products; and tomato seeds. In addition, it provides antibacterial, vitamin and mineral, feed additive, anti-inflammatory, and anti-parasite health products for animal; poultry health products; and pet care products and pet foods. Hektas Ticaret T.A.S. was founded in 1956 and is headquartered in Gebze, Turkey.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.04B | 5.24B | 2.02B | 1.01B | 732.68M | 497.07M | 252.21M | 176.78M | 160.97M | 138.75M | 113.00M | 117.45M | 102.06M | 84.63M | 74.94M |
| Cost of Revenue | 5.22B | 3.14B | 1.31B | 662.41M | 419.08M | 273.75M | 156.21M | 108.17M | 101.44M | 87.84M | 69.03M | 73.33M | 63.94M | 52.59M | 55.13M |
| Gross Profit | 815.59M | 2.10B | 708.32M | 351.31M | 313.60M | 223.32M | 96.00M | 68.61M | 59.53M | 50.91M | 43.97M | 44.12M | 38.12M | 32.05M | 19.80M |
| Gross Profit Ratio | 13.51% | 40.11% | 35.05% | 34.66% | 42.80% | 44.93% | 38.06% | 38.81% | 36.98% | 36.69% | 38.91% | 37.56% | 37.35% | 37.86% | 26.42% |
| Research & Development | 208.19M | 84.69M | 31.27M | 18.27M | 11.53M | 1.71M | 62.67K | 72.61K | 72.61K | 72.61K | 42.41K | 12.76K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 178.78M | 77.57M | 19.02M | 9.73M | 4.63M | 4.80M | 2.78M | 2.40M | 2.99M | 2.02M | 1.64M | 1.63M | 9.48M | 7.78M | 6.94M |
| Selling & Marketing | 209.18M | 84.91M | 26.60M | 13.69M | 9.64M | 8.17M | 7.90M | 5.42M | 4.56M | 6.61M | 5.23M | 4.76M | 11.84M | 9.73M | 8.60M |
| SG&A | 387.95M | 162.48M | 45.63M | 23.42M | 14.27M | 12.97M | 10.69M | 7.82M | 7.56M | 8.64M | 6.87M | 6.38M | 21.32M | 17.50M | 15.54M |
| Other Expenses | 1.68B | 259.91M | 117.40M | 67.19M | 38.79M | 30.21M | 323.31K | 295.98K | 271.51K | 271.40K | 253.40K | 57.54K | -302.06K | -426.20K | 1.68M |
| Operating Expenses | 2.27B | 507.09M | 194.30M | 108.89M | 64.60M | 44.89M | 33.64M | 30.70M | 26.51M | 25.91M | 22.67M | 21.72M | 21.02M | 17.08M | 17.23M |
| Cost & Expenses | 7.50B | 3.64B | 1.51B | 771.29M | 483.68M | 318.64M | 189.85M | 138.87M | 127.95M | 113.75M | 91.70M | 95.05M | 84.96M | 69.67M | 72.36M |
| Interest Income | 408.87M | 92.69M | 17.22M | 2.79M | 2.09M | 4.12M | 9.81M | 7.05M | 5.37M | 4.30M | 2.32M | 4.54M | 4.65M | 9.73M | 7.96M |
| Interest Expense | 3.90B | 948.28M | 206.40M | 89.38M | 98.85M | 57.60M | 8.87M | 4.97M | 2.47M | 1.54M | 1.03M | 3.23M | 1.06M | 6.77M | 3.27M |
| Depreciation & Amortization | 545.45M | 99.39M | 52.48M | 27.03M | 13.54M | 5.40M | 3.56M | 2.76M | 2.62M | 2.27M | 2.24M | 2.05M | 1.86M | 1.38M | 7.96M |
| EBITDA | 3.06B | 1.74B | 586.11M | 270.58M | 259.51M | 181.90M | 72.53M | 43.26M | 34.68M | 31.35M | 25.63M | 29.30M | 18.99M | 16.34M | 10.53M |
| EBITDA Ratio | 50.59% | 30.28% | 28.99% | 26.78% | 35.46% | 36.37% | 29.68% | 25.32% | 22.27% | 22.51% | 22.69% | 25.12% | 18.58% | 30.81% | 14.05% |
| Operating Income | -791.22M | 1.42B | 429.44M | 239.07M | 245.27M | 164.60M | 68.60M | 40.35M | 37.02M | 30.03M | 23.99M | 22.54M | 17.10M | 14.97M | 2.57M |
| Operating Income Ratio | -13.10% | 27.09% | 21.25% | 23.58% | 33.48% | 33.11% | 27.20% | 22.83% | 23.00% | 21.64% | 21.23% | 19.19% | 16.75% | 17.68% | 3.44% |
| Total Other Income/Expenses | -723.63M | -484.66M | -96.09M | -88.41M | -100.34M | -46.67M | -6.84M | -3.66M | -6.75M | -1.96M | -1.83M | -1.29M | -1.03M | 2.96M | 4.69M |
| Income Before Tax | -1.51B | 544.66M | 334.33M | 158.87M | 145.39M | 118.23M | 61.76M | 36.70M | 30.47M | 27.89M | 22.51M | 24.31M | 16.07M | 17.93M | 7.26M |
| Income Before Tax Ratio | -25.08% | 10.40% | 16.55% | 15.67% | 19.84% | 23.79% | 24.49% | 20.76% | 18.93% | 20.10% | 19.92% | 20.70% | 15.75% | 21.19% | 9.69% |
| Income Tax Expense | -620.40M | -244.36M | 8.57M | -29.46M | -184.94K | 12.04M | 12.52M | 7.35M | 6.22M | 5.67M | 4.47M | 4.86M | 3.19M | 3.56M | 1.59M |
| Net Income | -878.24M | 802.29M | 319.39M | 178.66M | 145.57M | 106.19M | 49.24M | 29.34M | 24.25M | 22.22M | 18.03M | 19.45M | 12.88M | 14.37M | 5.67M |
| Net Income Ratio | -14.54% | 15.32% | 15.81% | 17.62% | 19.87% | 21.36% | 19.52% | 16.60% | 15.06% | 16.02% | 15.96% | 16.56% | 12.62% | 16.98% | 7.57% |
| EPS | -0.35 | 0.59 | 0.11 | 0.04 | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.35 | 0.59 | 0.11 | 0.04 | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 2.53B | 1.35B | 3.02B | 4.72B | 2.34B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 4.02B |
| Weighted Avg Shares Out (Dil) | 2.53B | 1.35B | 3.02B | 4.72B | 2.34B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 3.77B | 4.02B |
Source: https://incomestatements.info
Category: Stock Reports